Skip to content

Author

Shogen Boku

We have 2 of 89 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Sterile neutrophilic pseudomembranous conjunctivitis associated with tisotumab vedotin: clinical and cytological evidence from two cases

Tisotumab vedotin-tfTV (TV), an antibody-drug conjugate (ADC), represents a significant advancement in cancer therapy but carries the potential to induce ocular surface toxicity. Having encountered ocular side effects with TV and obtained intriguing findings from histological examination, we discuss the pathophys...

K. Araki-Sasaki, Shogen Boku, Megumi Kitamura et al. · 0 citations
Review Open access Jul 2026

AI-integrated multi-omics platform to revolutionize anti-metastatic therapy development through circulating tumor cell profiling: SCRUM-MONSTAR-CTC

It is proposed that the next phase of precision oncology should integrate the cellular dimension of metastasis through systematic circulating tumor cell (CTC) profiling and highlights adherent-to-suspension transition (AST) as one representative, experimentally tractable plasticity program that enables tumor cells to s...

T. Hashimoto, T. Shibuki, T. Fujisawa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.